drugset / Trial / NCT06495437

Preliminary Safety and Efficacy Study of Extracellular Vesicle Infusion in the Intervention of Age-related Phenotypes With Impaired Glucose Tolerance.

NCT06495437 ↗

Not yet recruiting 20 enrolled BEAUTECH
NaSingle-groupOpen-labelTreatment

Summary

The objective of this exploratory study was to evaluate the initial safety of human mesenchymal stem cell-derived extracellular vesicle infusion in an age-related phenotype with impaired glucose tolerance

Timeline

Start
2024-08-01
Primary completion
2026-08-01
Completion
2026-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject extracellular vesicle preparation Unknown 100 ml Intravenous

Indications